Data

The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia

University of New South Wales
University of New South Wales. Faculty of Medicine. Lowy Cancer Research Centre. Adult Cancer Program (Associated with)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=http://hdl.handle.net/1959.4/004_279&rft.title=The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia&rft.identifier=http://hdl.handle.net/1959.4/004_279&rft.publisher=University of New South Wales&rft.description=This project was established to conduct a long-term evaluation of the way in which bevacizumab (Avastin) is used to treat metastatic colorectal cancer in the real world clinical setting. Bevacizumab became available under the Pharmaceutical Benefits Scheme (PBS) in July 2009. This study has access to the PBS history of all patients prescribed bevacizumab since its PBS-subsidy and has approval for annual data updates until 2016. &rft.creator=Anonymous&rft.date=2013&rft.coverage=Australia&rft_rights= Access to the data is subject to originating data custodian approval. Ethics committee approval and other access conditions apply. Contact the Information Officer for more information: info.acp@unsw.edu.au. &rft_subject=Oncology and Carcinogenesis not elsewhere classified&rft_subject=MEDICAL AND HEALTH SCIENCES&rft_subject=ONCOLOGY AND CARCINOGENESIS&rft_subject=Clinical Pharmacology and Therapeutics&rft_subject=PHARMACOLOGY AND PHARMACEUTICAL SCIENCES&rft_subject=Public Health and Health Services not elsewhere classified&rft_subject=PUBLIC HEALTH AND HEALTH SERVICES&rft_subject=Pharmacoepidemiology&rft_subject=Drug treatments&rft_subject=Patterns of cancer care&rft.type=dataset&rft.language=English Access the data

Please use the contact information below to request access to this data.

Contact Information

Street Address:
Adult Cancer Program, Lowy Cancer Research Centre, Faculty of Medicine, The University of New South Wales



Licence & Rights:

view details

Access to the data is subject to originating data custodian approval. Ethics committee approval and other access conditions apply. Contact the Information Officer for more information: info.acp@unsw.edu.au.

Access:

Other view details

Access type: Access by request.

Full description

This project was established to conduct a long-term evaluation of the way in which bevacizumab (Avastin) is used to treat metastatic colorectal cancer in the real world clinical setting. Bevacizumab became available under the Pharmaceutical Benefits Scheme (PBS) in July 2009. This study has access to the PBS history of all patients prescribed bevacizumab since its PBS-subsidy and has approval for annual data updates until 2016.

Notes

Originating source(s): Medicare Australia [Pharmaceutical Benefits Scheme] [Patient/Medicare enrolment data]
Click to explore relationships graph

Spatial Coverage And Location

text: Australia

Identifiers